UGREEN to Showcase Pioneering NASync AI NAS Lineup and More at CES 2025
LAS VEGAS, Nev. — January 7, 2025 — UGREEN, a leading innovator in consumer electronics, is due to showcase its latest innovations at CES 2025 under the theme of “Activate…
Linker Vision Unveils the Future of Smart Cities at CES 2025: Showcasing Innovative VLM and GenAI
LAS VEGAS, Nev. — January 7, 2025 — Linker Vision revealed its groundbreaking technologies at CES 2025, featuring its latest GenAI Observ platform, VLM (Vision Language Model), and LVM (Large…
Mili emerges from stealth with its enterprise AI platform for wealth management firms and $2 million in seed funding
PLANO, Tex. — January 7, 2025 — Mili, AI meeting documentation platform for wealth management firms, has raised $2 million in seed funding led by Chiratae and BoldCap, with participation…
Oracle Exadata X11M Delivers Extreme Performance, Increased Efficiency, and Improved Energy Savings for Data and AI Workloads
Next-generation intelligent data architecture delivers up to 55 percent faster AI Vector searches, 2.2X faster analytics scan throughput, and 25 percent faster transaction processing—at the same price as the previous…
GIGABYTE Unveils a diverse lineup of AI PCs with Groundbreaking GiMATE AI Agent at CES 2025
TAIPEI, Taiwan — January 8, 2025 — GIGABYTE, the world’s leading computer brand, unveiled its next-gen AI PCs at CES 2025. GiMATE, a groundbreaking AI agent for seamless hardware and…
Narrative Unveils LLM Fine-Tuning Platform and Rosetta Stone 2.0, Pioneering a New Era of Data Normalization and Custom Model Training
NEW YORK, N.Y. — January 7, 2025 — Narrative, the industry’s leading data collaboration and commerce platform, today announced a groundbreaking suite of enhancements aimed at democratizing AI development and…
Old World Labs at CES 2025: Integrating Agents into Humanoid Robots and Virtual Worlds
LAS VEGAS, Nev. — January 7, 2025 — Old World Labs (OWL) is thrilled to unveil its revolutionary “Agents as a Service” technology at CES 2025, showcasing its seamless integration…
Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease
CAMBRIDGE, Mass. — January 7, 2025 — Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announces positive results from two Phase I studies…
QuickLogic Announces Strategic Process for SensiML
SAN JOSE, Calif. — January 7, 2025 — QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) Hard IP and ruggedized FPGAs, today announced its Board of Directors is…
Inari Raises $144 Million, Paving Path to Long-Term Growth
The SEEDesign™ company secured significant support from new and returning investors as it seeks to redefine the seed technology landscape. CAMBRIDGE, Mass. — January 7, 2025 — Inari, the SEEDesign™…